Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan's Botox Migraine Review Extended Three Months by U.S. Regulators
Allergan's Botox Migraine Review Extended Three Months by U.S. Regulators
Allergan's Botox Migraine Review Extended Three Months by U.S. Regulators
Submitted by
admin
on August 2, 2010 - 8:34pm
Source:
Bloomberg
News Tags:
Allergan
FDA
migraines
Botox
Headline:
Allergan's Botox Migraine Review Extended Three Months by U.S. Regulators
Do Not Allow Advertisers to Use My Personal information
